I am a
Home I AM A Search Login

Papers of the Week

2022 Sep 30

J Headache Pain



A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.


Wu S, Ren X, Zhu C, Wang W, Zhang K, Li Z, Liu X, Wang Y
J Headache Pain. 2022 Sep 30; 23(1):128.
PMID: 36180824.


Chronic migraine is a common and highly disabling disorder. Functional MRI has indicated that abnormal brain region activation is linked with chronic migraine. Drugs targeting the calcitonin gene-related peptide (CGRP) or its receptor have been reported to be efficient for treating chronic migraine. The CGRP signaling was also shared in two types of chronic migraine models (CMMs). However, it remains unclear whether the activation of specific brain regions could contribute to persistent behavioral sensitization, and CGRP receptor antagonists relieve migraine-like pain in CMMs by altering specific brain region activation. Therefore, it's of great interest to investigate brain activation pattern and the effect of olcegepant (a CGRP receptor-specific antagonist) treatment on alleviating hyperalgesia by altering brain activation in two CMMs, and provide a reference for future research on neural circuits.